In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'. Nat Med 2007 Jan;13(1):14; author reply 15-6
Date
01/09/2007Pubmed ID
17206119DOI
10.1038/nm0107-14Scopus ID
2-s2.0-33846086176 (requires institutional sign-in at Scopus site) 35 CitationsAuthor List
Atallah E, Kantarjian H, Cortes JAuthor
Ehab L. Atallah MD Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Antineoplastic AgentsBenzamides
Heart Failure
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Neoplasms
Piperazines
Pyrimidines